Market Indices
Latest News
| ||
|
Price Targets
from CLSA issued a price target of $6.10 for MLCO on 2026-06-05 13:29:13.The adjusted price target was set to $6.10.At the time of the announcement, MLCO was...
June 5, 2026 MLCO 2.76%
from UBS issued a price target of $10.00 for MOMO on 2026-06-04 13:24:00.The adjusted price target was set to $10.00.At the time of the announcement, MOMO was...
June 4, 2026 MOMO 0.18%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| LXEH Lixiang Education Holding | 2.03
56.15% | ||||||||||||||||||
| IXHL Incannex Healthcare Limit | 3.51
20.03% | ||||||||||||||||||
| BQ Boqii Holding Limited | 0.82
13.04% | ||||||||||||||||||
| ALAR Alarum Technologies Ltd. | 9.95
11.67% | ||||||||||||||||||
| EH EHang Holdings Limited | 8.77
11.08% | ||||||||||||||||||
| YSG Yatsen Holding Limited | 2.92
9.77% | ||||||||||||||||||
| ADXN Addex Therapeutics Ltd | 6.41
9.39% | ||||||||||||||||||
| YJ Yunji Inc. | 1.74
7.79% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT -5.46%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA -2.97%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA -2.97%